Showing 2,961 - 2,980 results of 3,133 for search '"Bengaluru"', query time: 0.13s Refine Results
  1. 2961

    Clinical and Economic Burden Associated with Prolonged Air Leaks Among Patients Undergoing Thoracic Resection: A Retrospective Database Analysis by Johnson BH, Johnston SS, Tewari P, Afolabi M, Danker W III

    Published 2023-04-01
    “…Barbara H Johnson,1 Stephen S Johnston,1 Pranjal Tewari,2 Mosadoluwa Afolabi,1 Walter Danker III3 1Epidemiology, Johnson & Johnson, New Brunswick, NJ, USA; 2Data Sciences, Mu Sigma, Bengaluru, Karnataka, India; 3Ethicon Franchise Health Economics and Market Access, Johnson & Johnson, Raritan, NJ, USACorrespondence: Barbara H Johnson, Real-World Data Analytics and Research, Epidemiology - MedTech, Johnson & Johnson, 410 George Street, New Brunswick, NJ, 08901, USA, Tel/Fax +1 603 616 6719, Email BJohns23@its.jnj.comPurpose: Prophylactic use of lung sealants among patients undergoing thoracic resection has been reported for the management of intraoperative air leaks and is associated with a lower incidence of prolonged air leak (PAL) and a shorter length of stay (LOS). …”
    Get full text
    Article
  2. 2962
  3. 2963
  4. 2964
  5. 2965
  6. 2966
  7. 2967
  8. 2968
  9. 2969
  10. 2970
  11. 2971
  12. 2972
  13. 2973
  14. 2974
  15. 2975

    Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial by Paly VF, Vallejo-Aparicio LA, Martin A, Izquierdo JL, Riesco JA, Soler-Cataluña JJ, Abreu C, Biswas C, Ismaila AS

    Published 2022-12-01
    “…Victoria Federico Paly,1 Laura Amanda Vallejo-Aparicio,2 Alan Martin,3 José Luis Izquierdo,4 Juan Antonio Riesco,5 Juan José Soler-Cataluña,6 Catarina Abreu,7 Chandroday Biswas,8 Afisi S Ismaila9,10 1ICON plc, Philadelphia, PA, USA; 2GSK, Madrid, Spain; 3GSK, Brentford, UK; 4Hospital Universitario de Guadalajara, Guadalajara, Spain; 5Hospital San Pedro de Alcántara, Cáceres, Spain; 6Hospital Arnau de Vilanova, Valencia, Spain; 7ICON Plc, New York, NY, USA; 8ICON Plc, Bengaluru, Karnataka, India; 9Value Evidence and Outcomes, GSK, Collegeville, PA, USA; 10Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, CanadaCorrespondence: Afisi S Ismaila, Value Evidence and Outcomes, GSK, 1250 South Collegeville Road, Collegeville, PA, 19426-0989, USA, Tel +1 919 315 8229, Email afisi.s.ismaila@gsk.comPurpose: Given between-country differences in healthcare systems, treatment costs, and disease management guidelines, country-specific cost-effectiveness analyses are important. …”
    Get full text
    Article
  16. 2976
  17. 2977
  18. 2978
  19. 2979
  20. 2980